These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8319661)

  • 1. Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment.
    Neumann HG; Birner G; Kowallik P; Schütze D; Zwirner-Baier I
    Environ Health Perspect; 1993 Mar; 99():65-9. PubMed ID: 8319661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships.
    Sabbioni G
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):61-7. PubMed ID: 7889861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring of aromatic amines V: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by haemoglobin binding.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1998; 72(8):499-504. PubMed ID: 9765065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin Adducts and Urinary Metabolites of Arylamines and Nitroarenes.
    Sabbioni G
    Chem Res Toxicol; 2017 Oct; 30(10):1733-1766. PubMed ID: 28933159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin binding of aromatic amines: molecular dosimetry and quantitative structure-activity relationships for N-oxidation.
    Sabbioni G
    Environ Health Perspect; 1993 Mar; 99():213-6. PubMed ID: 8319626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring of aromatic amines. III: Hemoglobin binding of benzidine and some benzidine congeners.
    Birner G; Albrecht W; Neumann HG
    Arch Toxicol; 1990; 64(2):97-102. PubMed ID: 2350241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes.
    Jones CR; Sabbioni G
    Chem Res Toxicol; 2003 Oct; 16(10):1251-63. PubMed ID: 14565767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.
    Neumann HG
    Int Arch Occup Environ Health; 1988; 60(3):151-5. PubMed ID: 3384479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin binding of nitroarenes and quantitative structure-activity relationships.
    Sabbioni G
    Chem Res Toxicol; 1994; 7(2):267-74. PubMed ID: 8199317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin binding of bicyclic aromatic amines.
    Sabbioni G; Schütze D
    Chem Res Toxicol; 1998 May; 11(5):471-83. PubMed ID: 9585478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin adducts and urine metabolites of 4,4'-methylenedianiline after 4,4'-methylenediphenyl diisocyanate exposure of rats.
    Sepai O; Schütze D; Heinrich U; Hoymann HG; Henschler D; Sabbioni G
    Chem Biol Interact; 1995 Jul; 97(2):185-98. PubMed ID: 7606816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
    Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
    Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolyzable hemoglobin adducts of polyfunctional monocyclic N-substituted arenes as dosimeters of exposure and markers of metabolism.
    Zwirner-Baier I; Kordowich FJ; Neumann HG
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):43-5. PubMed ID: 7889857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines.
    Birner G; Neumann HG
    Arch Toxicol; 1988; 62(2-3):110-5. PubMed ID: 3196145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation.
    Sabbioni G
    Chem Biol Interact; 1992 Jan; 81(1-2):91-117. PubMed ID: 1730150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hemoglobin as a dose monitor for alkylating and arylating agents.
    Neumann HG
    Arch Toxicol; 1984 Nov; 56(1):1-6. PubMed ID: 6517706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compounds.
    Carmella SG; Kagan SS; Spratt TE; Hecht SS
    Cancer Res; 1990 Sep; 50(17):5453-9. PubMed ID: 2201436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethanol and phenobarbital on hemoglobin adducts formation in rats exposed to benzidine and Direct Black 38.
    Kim KY; Roh JH; Lee SH; Won JU; Kim CN
    Ind Health; 2009 Aug; 47(4):383-92. PubMed ID: 19672012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hemoglobin adducts from a 4, 4'-methylenedianiline metabolite evidently produced by peroxidative oxidation in vivo.
    Kautiainen A; Wachtmeister CA; Ehrenberg L
    Chem Res Toxicol; 1998 Jun; 11(6):614-21. PubMed ID: 9625729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.